Related Experiment Videos
Beta-endorphin amplifies the effect of interleukin-1 on mouse mesangial cell proliferation
Abstract:
We report experiments that show that beta-endorphin, a neuropeptide, enhances the effect of interleukin-1 on mouse mesangial cell proliferation. Met-enkephalin, which comprises the first five amino acids of the beta-endorphin molecule, can also be shown to possess similar biologic activity. This action of beta-endorphin and met-enkephalin is mediated through naloxone-insensitive receptors on the mesangial cell, because naloxone treatment of the kidney cells does not abrogate this activity. The studies delineate a novel mechanism by which a neuropeptide may influence the development of immune-mediated cellular pathology.
Insights
Beta-endorphin and met-enkephalin, neuropeptides, enhance interleukin-1's effect on mouse mesangial cell proliferation via naloxone-insensitive receptors. This reveals a new pathway for neuropeptides in immune-mediated kidney cell pathology.
Area of Science:
- Immunology
- Neuroendocrinology
- Cell Biology
Background:
- Interleukin-1 (IL-1) is a key cytokine in immune responses.
- Neuropeptides, such as beta-endorphin, play roles in regulating cellular functions.
- Mouse mesangial cells are crucial for kidney function and are targets in immune-mediated diseases.
Purpose of the Study:
- To investigate the effect of beta-endorphin and met-enkephalin on mouse mesangial cell proliferation.
- To determine the receptor mechanism involved in this neuropeptide-mediated effect.
- To elucidate a novel pathway for neuropeptide influence on immune-mediated cellular pathology.
Main Methods:
- Cell culture of mouse mesangial cells.
- Treatment with beta-endorphin, met-enkephalin, and interleukin-1.
- Assessment of cell proliferation.
- Evaluation of naloxone's effect on the observed activities.
Main Results:
- Beta-endorphin was found to enhance the proliferative effect of interleukin-1 on mouse mesangial cells.
- Met-enkephalin demonstrated similar biological activity to beta-endorphin.
- The observed enhancement of proliferation was mediated through naloxone-insensitive receptors.
Conclusions:
- Neuropeptides beta-endorphin and met-enkephalin can modulate immune responses at the cellular level.
- A novel mechanism involving naloxone-insensitive receptors is identified for neuropeptide action on mesangial cells.
- These findings suggest a new role for neuropeptides in the pathogenesis of immune-mediated kidney diseases.